Evaluation of the Quality and Reliability of YouTube Videos With Turkish Content as an Information Source for Gynecological Cancers During the COVID-19 Pandemic.

Aim During the COVID-19 pandemic, YouTube became a critical information source for people seeking information about several diseases, including benign and malignant gynecological disorders. This study aimed to evaluate the quality and reliability of YouTube videos with Turkish content as an information source for gynecological cancers during the COVID-19 pandemic. Methods The research was performed between December 2nd and 5th, 2020. Two gynecologists searched the terms in Turkish; 'yumurtalik kanseri, COVID-19', 'rahim kanseri, coronavirus', 'rahim agzi kanseri, COVID-19', 'kadin üreme sistemi kanseri, coronavirus', and 'jinekolojik kanserler, COVID-19'. on YouTube. 'Yumurtalik kanseri', 'rahim kanseri', 'rahim agzi kanseri', 'kadin üreme sistemi kanserleri' and 'jinekolojik kanserler' are the translations for "ovarian cancer, COVID-19", "endometrial cancer, coronavirus", "cervical cancer, COVID-19", "female reproductive system cancers, coronavirus", and "gynecological cancers, COVID-19" in the Turkish language, respectively. Videos were categorized into three groups depending on the upload source: the informative group, the personal experience group, and the news agency group. Moreover, DISCERN, the Medical Information and Content Index (MICI), the Video Information and Quality Index (VIQI) were evaluated. Results A total of 57 videos were categorized as informative. Additionally, 22 videos and 18 videos were classified as patient experience videos and new agency videos, respectively. Patients who experienced videos had a significantly higher view number (p=0.001). The number of dislikes and DISCERN score were markedly better in favor of informative videos (p=0.009 and p=0.001). The MICI score was calculated as 13.0±1.8 for informative videos. The total VIQI score was 11.9 for informative videos, 8.8 for patient experience videos, and 7.2 for new agency videos (p = 0.001). Conclusions YouTube videos with Turkish content about gynecological cancers are easily accessible resources during the COVID-19 pandemic. Patient-published videos are the most preferred YouTube videos by Turkish citizens, and informative videos have a considerably lower dislike rate. According to the MICI score and significantly better DISCERN and VIQI scores, informative videos have acceptable quality.

Effects of information sources in HPV vaccine acceptance: prospective randomized trial.

BACKGROUND: No study has evaluated the impact of written and visual resources in addition to information provided by healthcare workers on the acceptance of the HPV vaccine, which is the focus of the present research. METHODS: This prospective study was conducted between September 2020 and June 2021. The first group (Group 1) was given a 20-minute informative talk by professional healthcare providers about the benefits of HPV vaccination. For Group 2, the talk from the professional healthcare worker was supplemented with a 1200-word, three-page written information source about the HPV vaccine that was given to patients. In Group 3, participants again received information from professional healthcare providers, supplemented with video content. One week after the first visit, participants' acceptance status of the HPV vaccination and concerns about the administration of HPV vaccine were reevaluated. RESULTS: At the end of the study period, 225 participants (75 for each group) were enrolled. After the education protocol, concerns about the HPV vaccination significantly decreased in Group 3 in compared with the other groups (p = 0.001). The HPV vaccine acceptance rate increased from 26.7% to 56.0% in group 1, from 24.0% to 58.7% in group 2, and from 28.0% to 82.7% in group 3 (p = 0.001). CONCLUSION: The present study showed that information from the video supplementing the professional health worker's talk was associated with significantly lower anxiety and concern level about the HPV vaccine, and significantly higher the HPV vaccine acceptance rate.

Assessment of factors affecting attitudes and knowledge of pregnant women about COVID-19 vaccination.

The aim of this study was to analyse knowledge and attitudes of pregnant women about Coronavirus disease (COVID-19) and its vaccine. Pregnant women who attended outpatient maternal care between October 2020 and March 2021 were invited to participate in this cross-sectional survey study. To identify the effect of baseline characteristics of participants on their vaccination decision, the pregnant women were divided into two groups as accepting or rejecting the COVID-19 vaccine. The Multiparity rate was significantly higher in the rejection group (73.8 vs. 42.3, p = .001). Education level and rate of employment in the professional health sector were significantly higher in the acceptance group (p = .001 and p = .008). A total of 103 (26.4%) pregnant women from the acceptance group, and 23 (10.9%) from the rejection group had a history of the death of relatives and acquaintances from COVID-19 (p = .001). The present study demonstrated that nulliparous status, higher education level, working as a professional healthcare provider and incidence of death in relatives due to COVID-19 significantly rise pregnant women's acceptance of the COVID-19 vaccine. Considering the overall acceptance rate of 65%, improved vaccination programmes using all types of information sources need to be the main task to block the COVID-19 pandemic. IMPACT STATEMENTWhat is already known on this subject? There are previous studies that evaluated the attitudes and beliefs about several vaccine types among pregnant women. An important part of tackling the COVID-19 pandemic is the success of the COVID-19 vaccination program in pregnant women. In this respect, it is important to know the attitudes of pregnant women regarding COVID-19 vaccination.What do the results of this study add? The baseline characteristics of pregnant women with or without acceptance of COVID-19 vaccination were similar regarding COVID-19 infection. The rates of being not multiparous and a health worker were higher in women with acceptance of COVID-19 vaccination. The rate of loss of relatives was also higher in women with acceptance of COVID-19 vaccination. In women without acceptance of COVID-19 vaccination, the major drawback was related to the possibility of harm to their baby's and own health.What are the implications of these findings for clinical practice and/or further research? In pregnant women, the attitude to COVID-19 vaccination may be modifiable by the design of focussed information media with respect to their education, occupation, and parity. Longitudinal studies are needed to determine whether this approach can effectively increase the rate of COVID-19 vaccination in pregnant women.

Effects of HPV Positivity in Women on Couples Sexual Behavior.

We aimed to analyze the effect of HPV positivity in women, on women's psychology, sexual health, and male sexuality. Participants in the study were sexually active patients with high-risk HPV positivity and without any cancerous and precancerous lesions in the pathological examination. Participants and their partners' sexual health were evaluated with the FSFI questionnaire and the International Index of Erectile Function (IIEF) Score. The Beck anxiety inventory (BAI) form was used to determine participants' anxiety status. The presence of premature ejaculation was analyzed using the premature ejaculation diagnosis tool (PEDT) form. Comparison of FSFI scores at the time of diagnosis and one month later revealed a significant decrease (18.1 vs 15.1, p = 0.001). Partners' IEFF score decreased from 27.7 at diagnosis to 25.5(p = 0.001). The mean BAI score rose from 13.9 at diagnosis to 25.5 one month later (p = 0.001). Participants' partners had a significantly worse PEDT score one month after diagnosis (6.0 vs 10.8, p = 0.001). The present study demonstrated a significant deterioration in female psychological and sexual health caused by HPV positivity. Moreover, after their partner's diagnosis with HPV positivity, men were significantly more likely to suffer from erectile dysfunction and premature ejaculation.

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study.

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate the role of dopamine agonist as a preventive strategy of OHSS in women at high risk in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment cycles. METHODS: Seventy women at risk to develop OHSS undergoing IVF/ICSI treatment cycle were included. The study group received 0.5 mg of cabergoline for 8 days from the day of human chorionic gonadotropin administration in comparison to those who undergo no treatment for the prevention of OHSS. The reduction of the incidence of OHSS was the primary outcome. RESULTS: The actual incidence of OHSS was 8.33% in the cabergoline group and 20.58% in the control group. Thus, the incidence of OHSS was significantly reduced, by almost 60%, in the cabergoline group in comparison with the control group (relative ratios: 0.4, 95% confidence interval: 0.18-0.79). CONCLUSION: Prophylactic treatment with the dopamine agonist, cabergoline, reduces the incidence of OHSS in women at high risk undergoing IVF/ICSI treatment. However, the effects of cabergoline on important outcomes, namely, live birth, miscarriage, and congenital abnormalities are still uncertain.